Cardiovascular Systems Stock Forecast, Price & News

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardiovascular Systems in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Cardiovascular Systems stock.
View analyst ratings for Cardiovascular Systems or view top-rated stocks.

Wall Street analysts have given Cardiovascular Systems a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cardiovascular Systems wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Cardiovascular Systems saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 1,330,000 shares, an increase of 18.8% from the June 30th total of 1,120,000 shares. Based on an average daily volume of 219,200 shares, the days-to-cover ratio is presently 6.1 days. Currently, 3.4% of the company's shares are short sold.
View Cardiovascular Systems' Short Interest.

Cardiovascular Systems is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Cardiovascular Systems.

Cardiovascular Systems will be holding an earnings conference call on Wednesday, August 4th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

Cardiovascular Systems, Inc. (NASDAQ:CSII) issued its earnings results on Thursday, May, 6th. The medical device company reported ($0.15) EPS for the quarter, missing the consensus estimate of ($0.10) by $0.05. The medical device company earned $63.30 million during the quarter, compared to analysts' expectations of $63.18 million. Cardiovascular Systems had a negative net margin of 10.11% and a negative trailing twelve-month return on equity of 8.62%. The business's quarterly revenue was up 3.4% on a year-over-year basis. During the same period in the prior year, the business earned ($0.08) earnings per share.
View Cardiovascular Systems' earnings history.

Cardiovascular Systems' stock was trading at $36.32 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CSII shares have increased by 3.4% and is now trading at $37.57.
View which stocks have been most impacted by COVID-19.

Cardiovascular Systems issued an update on its fourth quarter 2021 earnings guidance on Thursday, May, 27th. The company provided earnings per share guidance of - for the period. The company issued revenue guidance of $67 million-$70 million, compared to the consensus revenue estimate of $69.78 million.

6 brokerages have issued 1-year target prices for Cardiovascular Systems' shares. Their forecasts range from $38.75 to $50.00. On average, they anticipate Cardiovascular Systems' stock price to reach $45.29 in the next year. This suggests a possible upside of 20.6% from the stock's current price.
View analysts' price targets for Cardiovascular Systems or view top-rated stocks among Wall Street analysts.

12 employees have rated Cardiovascular Systems CEO Scott Ward on Glassdoor.com. Scott Ward has an approval rating of 81% among Cardiovascular Systems' employees.

Some companies that are related to Cardiovascular Systems include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), IDEXX Laboratories (IDXX), DexCom (DXCM), ResMed (RMD), Baxter International (BAX), Hologic (HOLX), STERIS (STE), Insulet (PODD) and Teleflex (TFX).
View all of CSII's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), (XEL), ACADIA Pharmaceuticals (ACAD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) and The Procter & Gamble (PG).

Cardiovascular Systems trades on the NASDAQ under the ticker symbol "CSII."

Cardiovascular Systems' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include New York State Common Retirement Fund (1.93%), Peregrine Capital Management LLC (0.89%), Exchange Traded Concepts LLC (0.23%), Rice Hall James & Associates LLC (0.23%), Cambiar Investors LLC (0.19%) and Victory Capital Management Inc. (0.15%). Company insiders that own Cardiovascular Systems stock include Alexander Rosenstein, Erik Paulsen, Martha Goldberg Aronson, Rhonda J Robb, Sandra Sedo and Scott R Ward.
View institutional ownership trends for Cardiovascular Systems.

CSII stock was sold by a variety of institutional investors in the last quarter, including Rice Hall James & Associates LLC, Peregrine Capital Management LLC, New York State Common Retirement Fund, Victory Capital Management Inc., MAI Capital Management, and Arizona State Retirement System. Company insiders that have sold Cardiovascular Systems company stock in the last year include Alexander Rosenstein, and Sandra Sedo.
View insider buying and selling activity for Cardiovascular Systems or view top insider-selling stocks.

CSII stock was acquired by a variety of institutional investors in the last quarter, including Cambiar Investors LLC, Exchange Traded Concepts LLC, Advisor Group Holdings Inc., 6 Meridian, Alliancebernstein L.P., Handelsbanken Fonder AB, Epiq Partners LLC, and State of Alaska Department of Revenue. Company insiders that have bought Cardiovascular Systems stock in the last two years include Erik Paulsen, Martha Goldberg Aronson, Rhonda J Robb, and Scott R Ward.
View insider buying and selling activity for Cardiovascular Systems or or view top insider-buying stocks.

Shares of CSII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CSII stock can currently be purchased for approximately $37.57.

Cardiovascular Systems has a market capitalization of $1.51 billion and generates $236.54 million in revenue each year. The medical device company earns $-27,240,000.00 in net income (profit) each year or ($0.79) on an earnings per share basis.

Cardiovascular Systems employs 779 workers across the globe.

The official website for Cardiovascular Systems is www.csi360.com.

Cardiovascular Systems is headquartered at 1225 OLD HWY 8 NW, ST. PAUL MN, 55112.

Cardiovascular Systems' mailing address is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. The medical device company can be reached via phone at 651-259-1600 or via email at [email protected]